Prudential Financial Inc Nektar Therapeutics Transaction History

Prudential Financial Inc

  • $70 Billion
  • Q3 2024

A detailed history of Prudential Financial Inc transactions in Nektar Therapeutics stock. As of the latest transaction made, Prudential Financial Inc holds 56,260 shares of NKTR stock, worth $65,824. This represents 0.0% of its overall portfolio holdings.

Number of Shares
56,260
Previous 56,260 -0.0%
Holding current value
$65,824
Previous $69,000 5.8%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$0.9 - $1.83 $14,454 - $29,389
16,060 Added 39.95%
56,260 $69,000
Q1 2024

May 14, 2024
BUY
$0.49 - $0.96 $5,880 - $11,520
12,000 Added 42.55%
40,200 $37,000
Q4 2023

Feb 13, 2024
BUY
$0.42 - $0.57 $3,192 - $4,332
7,600 Added 36.89%
28,200 $15,000
Q3 2023

Nov 13, 2023
BUY
$0.51 - $1.05 $10,506 - $21,630
20,600 New
20,600 $12,000
Q1 2023

May 12, 2023
SELL
$0.64 - $3.15 $4,224 - $20,790
-6,600 Reduced 3.51%
181,585 $127,000
Q4 2022

Feb 14, 2023
SELL
$2.03 - $4.28 $3,653 - $7,704
-1,800 Reduced 0.95%
188,185 $0
Q3 2022

Nov 04, 2022
SELL
$3.04 - $5.14 $7,797 - $13,184
-2,565 Reduced 1.33%
189,985 $608,000
Q2 2022

Aug 15, 2022
BUY
$3.17 - $6.17 $21,048 - $40,968
6,640 Added 3.57%
192,550 $732,000
Q1 2022

May 13, 2022
SELL
$4.16 - $13.72 $11,252 - $37,112
-2,705 Reduced 1.43%
185,910 $1 Million
Q4 2021

Feb 14, 2022
BUY
$10.83 - $18.41 $1.86 Million - $3.17 Million
172,015 Added 1036.23%
188,615 $2.55 Million
Q3 2021

Nov 15, 2021
SELL
$13.07 - $18.84 $8,430 - $12,151
-645 Reduced 3.74%
16,600 $298,000
Q2 2021

Aug 16, 2021
SELL
$16.52 - $20.4 $119,654 - $147,757
-7,243 Reduced 29.58%
17,245 $296,000
Q1 2021

May 12, 2021
BUY
$16.56 - $25.46 $5,796 - $8,911
350 Added 1.45%
24,488 $490,000
Q4 2020

Feb 16, 2021
SELL
$15.77 - $19.03 $630 - $761
-40 Reduced 0.17%
24,138 $410,000
Q3 2020

Nov 16, 2020
SELL
$16.59 - $24.79 $4,811 - $7,189
-290 Reduced 1.19%
24,178 $401,000
Q2 2020

Aug 12, 2020
SELL
$16.86 - $23.44 $1.64 Million - $2.28 Million
-97,250 Reduced 79.9%
24,468 $566,000
Q1 2020

May 12, 2020
BUY
$14.47 - $27.96 $103,171 - $199,354
7,130 Added 6.22%
121,718 $2.17 Million
Q4 2019

Feb 11, 2020
SELL
$15.87 - $23.12 $564,178 - $821,916
-35,550 Reduced 23.68%
114,588 $2.47 Million
Q3 2019

Nov 13, 2019
SELL
$16.91 - $36.27 $26,210 - $56,218
-1,550 Reduced 1.02%
150,138 $2.74 Million
Q2 2019

Aug 08, 2019
SELL
$31.0 - $36.3 $40,300 - $47,189
-1,300 Reduced 0.85%
151,688 $0
Q1 2019

May 15, 2019
SELL
$31.58 - $46.35 $732,150 - $1.07 Million
-23,184 Reduced 13.16%
152,988 $0
Q4 2018

Feb 07, 2019
BUY
$30.43 - $56.65 $167,486 - $311,801
5,504 Added 3.22%
176,172 $5.79 Million
Q3 2018

Nov 07, 2018
BUY
$46.46 - $68.49 $24,112 - $35,546
519 Added 0.31%
170,668 $0
Q2 2018

Aug 13, 2018
SELL
$46.25 - $104.45 $128,945 - $291,206
-2,788 Reduced 1.61%
170,149 $0
Q1 2018

May 04, 2018
SELL
$57.4 - $108.44 $4.92 Million - $9.3 Million
-85,746 Reduced 33.15%
172,937 $0
Q4 2017

Feb 13, 2018
SELL
$23.02 - $60.5 $34,530 - $90,750
-1,500 Reduced 0.58%
258,683 $15.4 Million
Q3 2017

Nov 02, 2017
BUY
$17.79 - $24.0 $4.63 Million - $6.24 Million
260,183
260,183 $6.24 Million

Others Institutions Holding NKTR

# of Institutions
147
Shares Held
139M
Call Options Held
32.6K
Put Options Held
14.1K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $219M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email